definiens: means, collectively, ( i ) OvaReX ®, BrevaReX ®, ProstaRex TM, AR54, and GivaRex TM, their formulations and methods of administration ; ( ii ) the Prior Development Technology ; ( iii ) Patents, Know - How, and Joint Intellectual Property, ( iv ) all Information relating to those certain antibodies known as OvaReX ®, BrevaReX ®, ProstaRex ™, AR54, and GivaRex ™ in the course of any work conducted pursuant to this Agreement, and ( v ) Improvements . The Licensed Technology does not include any technology, formulation, method of administration, Patents, Know - How, Information or Improvements ( collectively ) to the · extent any rights to such NIH Materials are granted to [COMPANY] under the NIH Agreement ( defined in Section 3.1 below ) which NIH Agreement expires as of June 11, 2002 . Upon [COMPANY] 's receipt prior to June 11, 2002 of UP 's written notice that UP would like to sublicense the rights to such NIH Materials granted to [COMPANY] under the NIH Agreement, such Materials shall automatically be included in Licensed Technology